Loading insider details...
Latest Form 4 (Jun 26, 2026): Grant/Award of 62,000 CCCC shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 26, 2026 | C4 Therapeutics, Inc. (CCCC) | Grant/Award | 62,000 | n/a |
| Feb 9, 2026 | Generation Bio Co. (GBIO) | Tender of Shares | 950 | n/a |
| Feb 3, 2026 | enGene Holdings Inc. (ENGN) | Grant/Award | 801,000 | n/a |
| Jun 20, 2025 | C4 Therapeutics, Inc. (CCCC) | Grant/Award | 35,500 | n/a |
| Jun 6, 2025 | Generation Bio Co. (GBIO) | Grant/Award | 30,000 | n/a |
| Jan 31, 2025 | enGene Holdings Inc. (ENGN) | Grant/Award | 850,000 | n/a |
| Oct 1, 2024 | enGene Holdings Inc. (ENGN) | Purchase | 10,000 | $57.0K |
| Jul 24, 2024 | enGene Holdings Inc. (ENGN) | Grant/Award | 1,250,000 | n/a |
| Jun 11, 2024 | C4 Therapeutics, Inc. (CCCC) | Grant/Award | 65,000 | n/a |
| Jun 10, 2024 | Generation Bio Co. (GBIO) | Grant/Award | 60,000 | n/a |